Company profile
SAGEbio LLC
SAGEbio aims at extending healthy life years by tackling chronic inflammations through proprietary Synbody technology
- Industry
- Biotechnology Research
- Employees
- 1
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2022
- LinkedIn followers
- 343
- Office locations
- 2
SAGEbio LLC company summary
SAGEbio LLC is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2022. On LinkedIn the company has around 1 employees and 343 followers. The company lists 2 office locations.
What technology does SAGEbio LLC use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About SAGEbio LLC
SAGEbio is dedicated to extending healthy life years by tackling chronic inflammations, which lead to long-term suffering and are contributing to nearly half of all deaths in high-income countries. Using its modular Synbody platform comprising engineered single-domain “synthetic antibodies” fused to an optimized pharmacokinetic domain, SAGEbio rapidly designs, assembles, and scales highly specific immunomodulators with tunable pharmacokinetics, superior tissue penetration, and strong developability. The company’s lead program is an anti-TL1A Synbody for subcutaneous applications that precisely modulates the TL1A:DR3 axis, a central switch in immune activation, to treat inflammatory bowel disease and other immune-mediated and fibrotic conditions without broad immunosuppression. By combining AI-supported discovery, an in-house nanobody library, and a plug-and-play Synbody architecture, SAGEbio is building a differentiated pipeline of next-generation anti-inflammatory therapies that merge the precision of biologics with the flexibility of synthetic scaffolds. SAGEbio is currently looking for early-stage partners and investors to help advance these programs into clinical trials.
Where is SAGEbio LLC located?
SAGEbio LLC lists 2 office locations.
Compare companies similar to SAGEbio LLC
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
SAGEbio LLC sagebio.tech | Biotechnology Research | 1 | 2022 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about SAGEbio LLC
What does SAGEbio LLC do?
SAGEbio is dedicated to extending healthy life years by tackling chronic inflammations, which lead to long-term suffering and are contributing to nearly half of all deaths in high-income countries. Using its modular Synbody platform comprising engineered single-domain “synthetic antibodies” fused to an optimized pharmacokinetic domain, SAGEbio rapidly designs, assembles, and scales highly specific immunomodulators with tunable pharmacokinetics, superior tissue penetration, and strong developability. The company’s lead program is an anti-TL1A Synbody for subcutaneous applications that precisely modulates the TL1A:DR3 axis, a central switch in immune activation, to treat inflammatory bowel disease and other immune-mediated and fibrotic conditions without broad immunosuppression. By combining AI-supported discovery, an in-house nanobody library, and a plug-and-play Synbody architecture, SAGEbio is building a differentiated pipeline of next-generation anti-inflammatory therapies that merge the precision of biologics with the flexibility of synthetic scaffolds. SAGEbio is currently looking for early-stage partners and investors to help advance these programs into clinical trials.
How many employees does SAGEbio LLC have?
SAGEbio LLC has around 1 employees on LinkedIn.
Where is SAGEbio LLC headquartered?
SAGEbio LLC is headquartered in Cambridge, Massachusetts.
Where does SAGEbio LLC have offices?
SAGEbio LLC lists 2 office locations, including Cambridge, Massachusetts, US; Thuwal, Mekka, SA.
When was SAGEbio LLC founded?
SAGEbio LLC was founded in 2022.
Build a lead list from companies like SAGEbio LLC
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.